These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
18. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. Roubey RA; Pratt CW; Buyon JP; Winfield JB J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218 [TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311 [TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Love PE; Santoro SA Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]